seloken stungulyf, lausn 1 mg/ml
recordati ireland limited* - metoprololum tartrat - stungulyf, lausn - 1 mg/ml
faslodex
astrazeneca ab - fulvestrant - brjóstakrabbamein - annarra meðferð, anti-estrógen - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. , Í leik - eða perimenopausal konur, samsetningu meðferð með palbociclib ætti að vera ásamt blóðkornunum á nýja-sjálandi (lhrh) örva.
maxidex augndropar, dreifa 1 mg/ml
novartis healthcare a/s - dexamethasonum fosfat - augndropar, dreifa - 1 mg/ml
vortil innrennslisstofn, lausn 200 mg
williams & halls ehf - voriconazolum inn - innrennslisstofn, lausn - 200 mg
ibandronic acid wh stungulyf, lausn 3 mg
williams & halls ehf - acidum ibandronicum mónónatríum - stungulyf, lausn - 3 mg
remurel (brabio 20 mg/ml stungulyf, lausn í áfylltri sprautu) stungulyf, lausn í áfylltri sprautu 20 mg/ml
zentiva k.s.* - glatiramer acetat - stungulyf, lausn í áfylltri sprautu - 20 mg/ml
movicol junior neutral mixtúruduft, lausn 6,9 g
norgine healthcare b.v. - macrogol 3350; sodium hydrogen carbonate; kalii chloridum; sodium chloride - mixtúruduft, lausn - 6,9 g
movicol mixtúruduft, lausn 13,8 g
norgine healthcare b.v. - macrogol 3350; sodium chloride; sodium hydrogen carbonate; kalii chloridum - mixtúruduft, lausn - 13,8 g
moviprep mixtúruduft, lausn
norgine b.v. - macrogol 3350; natrii sulfas; natrii chloridum; kalii chloridum; acidum ascorbicum inn; natrii ascorbas inn - mixtúruduft, lausn
pemetrexed wh (pemetrexed synthon) innrennslisþykkni, lausn 25 mg/ml
williams & halls ehf. - pemetrexedum inn - innrennslisþykkni, lausn - 25 mg/ml